KLF9 and cancer: The discovery of this mechanism not only reveals KLF9’s context-dependent role in cancer progression but also positions it as a promising therapeutic target, offering potential strategies to reverse macrophage-mediated immunosuppression and combat NPC metastasis through selective pathway modulation (72).